Debiopharm

It's #MedSafetyWeek ! Let's celebrate the daily efforts of our Pharmaceutical Safety teams in ensuring the safety of the products we develop. A big thank you to this team of dedicated professionals for making a meaningful difference in our patients' treatment journeys. 🙏🌟 #pharma #biotech #safety

"Back from the Philanthropic Trip to Asia" is a mini-series from our philanthropic foundation, Fondation Philanthropique Next. In it, our leadership team highlights the pivotal role that affiliate organizations play in the lives of young, less fortunate people living in Vietnam and Cambodia. In this first episode, our CEO, Bertrand Ducrey, and our Executive Director, Fabrice Paradies, share a few anecdotes from their visit to the REACH association in Vietnam. Discover more on the Next foundation: https://lnkd.in/eYKNWU24 #philantropy #humanitarian #support #developingcountries

Did you know that 50% of patients with chronic diseases struggle with treatment compliance? 📈 Christophe LELONG, founder of Vulgaroo, points out that a major cause is often the lack of clarity in medical instructions. To help address this, Christophe shows how the Vulgaroo platform can simplify medical reports, making them easier for patients to understand. Vulgaroo is one of the finalist innovations from the Patient’s Quality of Life Challenge, organized annually by Debiopharm, La Solution, and Inartis. Click here for more information on the challenge: https://lnkd.in/dYxDgkD   Follow Debiopharm and stay tuned for upcoming videos showcasing the contestants' brilliant inventions! 🌟 #challenge #innovation #qualityoflife #medical

Ready to embark on an unprecedented artistic journey? 🎭 The mythical character Prometheus, best known for defying the Olympian gods by stealing fire and giving it to humanity, will now be reimagined through an oncology lens by Centro Amazzone, a breast cancer association founded by women, for women. The performances will take place from November 14th to 15th in Palermo, Sicily, and we are proud to sponsor both the theatrical productions and the discussions surrounding cancer prevention and treatment. Follow Debiopharm to stay on top of our latest updates! #BreastCancerAwareness #arttherapy #oncology #patientssupport

Every year, the Swiss media Le Temps identifies 100 people who have given their time, energy, and imagination to make the French-speaking region of Switzerland shine. This year, our CEO Bertrand Ducrey was honored to be recognized in the 2024 edition of the “Forum des 100” for his consistent contribution to scientific innovation through his long-term career at Debiopharm, spanning from his beginnings as a formulation scientist to his leadership role over multiple sites today in Martigny and Lausanne.   We congratulate Bertrand Ducrey for this accomplishment and his example of how young scientists can grow in their roles and influence over time! Discover more about the members who guide and bring long-term vision to our company: https://lnkd.in/eYyyPfAw #leadership #switzerland #inspiration #pharma

Have you ever heard of Acromegaly? Do you know anyone with this condition? Acromegaly is a chronic, rare disease related to excessive production of growth hormone, with 9 out of 10 cases originating from a monoclonal benign pituitary tumor. What do patients experience? Patients can show progressive disfigurement primarily of the face and extremities. Sadly, it is often diagnosed late, in middle-age adults, due to it’s subtle progression, causing a variety of cardiovascular, respiratory, metabolic, musculoskeletal, neurological, and neoplastic comorbidities that might not be reversible with treatments that work to control the disease. At Debiopharm we are exploring how we can improve the quality of life and treatment convenience of people living with this condition. Today, on Acromegly Awarness Day, I invite you to learn more through the inspiring patient organization, Acromegaly Community. #rarediseases #acromegaly #clinicalresearch  https://lnkd.in/egH3873S

🌟 Our Innovation Fund portfolio companies will be attending BIO Europe 2024 in Stockholm next week, and we invite you to connect with them! BIO Europe is the main platform connecting the global biopharma community, and this year it will celebrate its 30th anniversary, bringing together over 5,500 delegates to participate in 30,000+ one-to-one meetings. 🔬 ViewsML Technologies – Platform virtualizing IHC to predict biomarker expression through AI. 📊 Risklick – Developer of AI software for clinical trial protocol development. 🧪 iktos – An AI-drug discovery platform offering generative drug design solutions. 🧬 WhiteLab Genomics – AI platform to accelerate the discovery and design of genomic therapies. 💻 BC Platforms – Technology platform for managing, accessing, and analysing Real-World Data . 🔗 Discover More: Ready to join us in supporting these pioneers who are shaping the future of biotechnology? Visit our website for more insights and opportunities 👉 https://lnkd.in/eiFyCkfW Let's connect at BIOEurope2024 and push the boundaries of innovation together! 🚀 #BIOEurope #AI #Innovation #Pharma #Healthcare

Are you attending BIO Europe 2024 as well? Our various teams are looking forward to meeting you! Get in touch today with our Business team (Anja Bitterwolf, Sandra von Meier, Mayte Ares Mejuto), our Search and Evaluation team (Damián Carvajal Ibáñez, PhD, Alberto Diaz Jimenez, PhD, Dr. Diana Pignalosa) team, our Alliance Management (Ilona Kotala) and our anti-infectives delegate (Morgane Vanbiervliet), to discuss opportunities to collaborate on fighting cancer and bacterial infections! See you in Stockholm! #BIOEurope #partnering #pharma #biotech

Each one of us has the opportunity to use our lives to make a difference in the world. Today we’d like to honor the life and legacy of Professor Andrew Schally (November 1926 – October 2024), the Nobel Prize winning research scientist who discovered the gonadotropin-releasing hormone leading to the synthesis of triptorelin. We are grateful for Prof. Schally’s impact and contribution to science and patient care. The discovery and develop triptorelin was a pivotal in our company's history and continues to have a profound impact on countless patients today.   Triptorelin, a GnRH agonist analogue, has become a cornerstone in the treatment of prostate cancer, offering a critical tool for managing the disease. More information on triptorelin 👉 https://lnkd.in/dqD-DX8P #prostatecancer #inspiration #drugdevelopment #nobelprize

Did you know that breast cancer patients are at higher risk of anxiety, depression, and early death in comparison to the general population? The importance of mental health challenges is undeniable, and the Centro Amazzone, a renowned Italian patient support group, recognizes the need. Volunteers like Rosaria have dedicated themselves to providing recurrent mental health check-ups, and she would like to do a quick exercise with you right now. What would your response be?   If you enjoyed this interview, consider following Debiopharm for more patient-centric content!   We believe that creative solutions like Centro Amazzone are offering women with breast cancer a better quality of life. Learn more about how we seek to ease patient disease burden here: https://lnkd.in/eZAttCq8